NCT04590950View on ClinicalTrials.gov

Dosage and PD Study of Eftrenonacog-alfa

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Severe Haemophilia B
Interventions
OTHER

Non interventional study

Non interventional study

Trial Locations (1)

75014

Service d'hématologie biologique - Hôpital Cochin, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04590950 - Dosage and PD Study of Eftrenonacog-alfa | Biotech Hunter | Biotech Hunter